Pregnancy Screening: NIPT, CVS and Amniocentesis Explained
Key message: Screening estimates the chance of a condition; it does not diagnose it. NIPT is a more…
Key message: Screening estimates the chance of a condition; it does not diagnose it. NIPT is a more accurate screening test for selected chromosome conditions, while CVS and amniocentesis can provide diagnostic information but are invasive.
Get urgent help: After CVS or amniocentesis, seek urgent advice for heavy bleeding, fluid leakage, regular contractions, fever, severe or worsening pain or feeling very unwell. Reduced movements later in pregnancy follow the maternity emergency pathway.
What is screening?
First-trimester combined screening uses maternal blood and ultrasound measurements within a defined gestation to estimate the chance of trisomy 21, 18 and 13. Later screening options depend on gestation and local programme.
Screening is optional and should be offered with information about possible results and next steps.
What is NIPT?
NIPT analyses cell-free placental DNA in maternal blood, usually from around 10 weeks. It has higher screening accuracy for common trisomies than traditional serum screening.
It remains a screening test: a high-chance result requires diagnostic confirmation before irreversible decisions, and a low-chance result cannot exclude every chromosome or genetic condition.
What can affect NIPT results?
- Low fetal fraction, early gestation or maternal weight.
- Placental mosaicism.
- A vanished twin or multiple pregnancy.
- Maternal chromosome or medical factors.
- The laboratory panel and quality standards.
What is CVS?
Chorionic villus sampling takes a small placental sample through the abdomen or cervix under ultrasound guidance, commonly in the first trimester after an appropriate gestational threshold.
It gives earlier diagnostic information, but because the sample is placental, rare mosaic results may require amniocentesis for clarification.
What is amniocentesis?
Amniocentesis takes a small sample of amniotic fluid through the abdomen under ultrasound guidance, usually from 15 weeks. Fetal cells are tested for the condition in question.
It is performed later than CVS and results may take different lengths depending on the test.
What are the risks of invasive testing?
CVS and amniocentesis carry a small procedure-related miscarriage risk in experienced hands, as well as uncommon bleeding, infection or fluid leakage. The exact figure varies by service and patient circumstances and should be provided by the testing unit.
RhD-negative patients may require Anti-D according to the procedure and protocol.
How is the choice made?
- The condition and certainty needed.
- Gestation and how quickly information is wanted.
- Ultrasound findings and prior screening chance.
- Twin or multiple pregnancy.
- Procedure risk and personal values.
- What the result would change for pregnancy care, birth or preparation.
What if a result is high chance or abnormal?
A fetal-medicine or genetic-counselling consultation should explain accuracy, possible diagnoses, confirmatory testing, uncertainty and all pregnancy options without pressure.
No screening result should be presented as a definite diagnosis.
What are the limits of a normal result?
A low-chance NIPT or normal diagnostic result for a specific condition does not guarantee a baby without any condition. The 20-week scan and routine pregnancy care remain important.
Expanded commercial panels should not be assumed to be equally validated for every condition.
Frequently asked questions
Is NIPT diagnostic?
No. It is highly accurate screening for selected conditions, but positive results need diagnostic confirmation.
Which is earlier, CVS or amniocentesis?
CVS is generally performed earlier; amniocentesis is usually from 15 weeks.
Does a normal NIPT replace the anomaly scan?
No. Ultrasound screens for structural conditions that NIPT does not assess.
Must I have testing after a high-chance result?
No. Testing is optional, and counselling should explain all choices.
Can twins have NIPT?
It may be available, but performance and interpretation differ and require an appropriate validated pathway.
Your next step
Ask what condition the test covers, whether it is screening or diagnostic, the local failure and procedure-risk figures, result time and what choices follow each result.
Medical and content review: Dr Mohamed Abdelghany, Obstetrics & Gynecology Specialist, MRCOG (UK), MSc Obstetrics & Gynecology – Kasr Al-Ainy, Cairo University.
Last reviewed: 23 August 2026.
This information is for general education and does not replace individual medical assessment. Severe, sudden or concerning symptoms should not wait for a routine appointment.
